Antidepressant-like activity of the neuropeptide Y Y5 receptor antagonist Lu AA33810: behavioral, molecular, and immunohistochemical evidence
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antidepressant-like activity of the neuropeptide Y Y5 receptor antagonist Lu AA33810: behavioral, molecular, and immunohistochemical evidence
Authors
Keywords
Astrocyte, Antidepressant, BDNF, Lu AA33810, GFAP, Neuropeptide Y, Prefrontal cortex, Gliotoxin, Forced swim test
Journal
PSYCHOPHARMACOLOGY
Volume 234, Issue 4, Pages 631-645
Publisher
Springer Nature
Online
2016-12-14
DOI
10.1007/s00213-016-4495-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Density of GFAP-immunoreactive astrocytes is decreased in left hippocampi in major depressive disorder
- (2016) J.A. Cobb et al. NEUROSCIENCE
- BDNF as a biomarker for successful treatment of mood disorders: A systematic & quantitative meta-analysis
- (2015) Maryna Polyakova et al. JOURNAL OF AFFECTIVE DISORDERS
- Epigenetic mechanisms underlying the role of brain-derived neurotrophic factor in depression and response to antidepressants
- (2015) F. Duclot et al. JOURNAL OF EXPERIMENTAL BIOLOGY
- Activation of mTOR dependent signaling pathway is a necessary mechanism of antidepressant-like activity of zinc
- (2015) Bernadeta Szewczyk et al. NEUROPHARMACOLOGY
- Antidepressant-like effect of zinc is dependent on signaling pathways implicated in BDNF modulation
- (2015) Luana M. Manosso et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- An excitatory synapse hypothesis of depression
- (2015) Scott M. Thompson et al. TRENDS IN NEUROSCIENCES
- Antidepressant-like effect of the mGluR5 antagonist MTEP in an astroglial degeneration model of depression
- (2014) Helena Domin et al. BEHAVIOURAL BRAIN RESEARCH
- Neuropeptide Y attenuates anxiety- and depression-like effects of cholecystokinin-4 in mice
- (2014) S.J. Desai et al. NEUROSCIENCE
- Enhanced inhibitory control by neuropeptide Y Y5 receptor blockade in rats
- (2014) A. Bari et al. PSYCHOPHARMACOLOGY
- High baseline BDNF serum levels and early psychopathological improvement are predictive of treatment outcome in major depression
- (2014) Thorsten Mikoteit et al. PSYCHOPHARMACOLOGY
- Glutamate system as target for development of novel antidepressants
- (2013) Mario Catena-Dell'Osso et al. CNS SPECTRUMS
- Magnolol treatment reversed the glial pathology in an unpredictable chronic mild stress-induced rat model of depression
- (2013) Lu-Fan Li et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484)
- (2013) M L Molendijk et al. MOLECULAR PSYCHIATRY
- Role of neuropeptides in anxiety, stress, and depression: From animals to humans
- (2013) Viktória Kormos et al. NEUROPEPTIDES
- Antidepressants act directly on astrocytes: Evidences and functional consequences
- (2012) Boldizsár Czéh et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Chronic administration of the Y2 receptor antagonist, JNJ-31020028, induced anti-depressant like-behaviors in olfactory bulbectomized rat
- (2012) J.C. Morales-Medina et al. NEUROPEPTIDES
- Acute antidepressant treatment differently modulates ERK/MAPK activation in neurons and astrocytes of the adult mouse prefrontal cortex
- (2012) B. Di Benedetto et al. NEUROSCIENCE
- Involvement of PKA, CaMKII, PKC, MAPK/ERK and PI3K in the acute antidepressant-like effect of ferulic acid in the tail suspension test
- (2012) Ana Lúcia Bertarello Zeni et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Discovery of Lu AA33810: A highly selective and potent NPY5 antagonist with in vivo efficacy in a model of mood disorder
- (2011) Mathivanan Packiarajan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Triple reuptake inhibitors for treating subtypes of major depressive disorder: the monoamine hypothesis revisited
- (2011) Jolanda Prins et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Central functions of neuropeptide Y in mood and anxiety disorders
- (2011) Gang Wu et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- A morphometric study of glia and neurons in the anterior cingulate cortex in mood disorder
- (2011) Rebecca A. Gittins et al. JOURNAL OF AFFECTIVE DISORDERS
- Involvement of PI3K, GSK-3β and PPARγ in the antidepressant-like effect of folic acid in the forced swimming test in mice
- (2011) Josiane Budni et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression
- (2011) Nadine Dreimüller et al. NEUROPHARMACOLOGY
- Role of neuropeptide Y Y1 and Y2 receptors on behavioral despair in a rat model of depression with co-morbid anxiety
- (2011) Julio César Morales-Medina et al. NEUROPHARMACOLOGY
- A possible role of neuropeptide Y in depression and stress
- (2009) Julio César Morales-Medina et al. BRAIN RESEARCH
- Emerging role of glutamate in the pathophysiology of major depressive disorder
- (2009) Kenji Hashimoto BRAIN RESEARCH REVIEWS
- Clomipramine treatment reversed the glial pathology in a chronic unpredictable stress-induced rat model of depression
- (2009) Qiong Liu et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugs
- (2009) Joanna M. Wierońska et al. NEUROCHEMISTRY INTERNATIONAL
- Glial Loss in the Prefrontal Cortex Is Sufficient to Induce Depressive-like Behaviors
- (2008) Mounira Banasr et al. BIOLOGICAL PSYCHIATRY
- Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice
- (2008) E. Painsipp et al. GENES BRAIN AND BEHAVIOR
- A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression
- (2008) André Russowsky Brunoni et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Unknown
- (2008) M. W. Walker et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole
- (2008) M Banasr et al. MOLECULAR PSYCHIATRY
- Monoaminergic compensation in the neuropeptide Y deficient mouse brain
- (2008) Donald R. Gehlert et al. NEUROPEPTIDES
- Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)–Y4 receptor knockout mice
- (2008) R.O. Tasan et al. NEUROSCIENCE
- Major Depressive Disorder
- (2008) R.H. Belmaker et al. NEW ENGLAND JOURNAL OF MEDICINE
- The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test
- (2008) Bernadeta Szewczyk et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Temporal expression of brain-derived neurotrophic factor (BDNF) mRNA in the rat hippocampus after treatment with selective and mixed monoaminergic antidepressants
- (2007) Marianne H. Larsen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started